Rampart1
Posted - 5 hours ago
$JAGX keep in mind jagx is all natural. JFK JR is all about all natural. Prepare for a launch up. π
Rampart1
Posted - 5 hours ago
$JAGX $CNSP $SBFM $ELAB in the past 4 years more than any algos and funders destroyed pennies with toxic offerings and a goal to short them to 0 if possible. Many are way oversold. Business susal will change soon and pennies will all run again.
David_Shitchery
Posted - 7 hours ago
$ELAB Based on this, I don't think a run is coming. https://www.streetinsider.com/Corporate+News/Elevai+Labs+%28ELAB%29+Files+for+28.37M+Share+and+Warrant+Offering/23724254.html As a matter of fact, I think this is just going to be like any other pipleine biotech like $JAGX, $SBFM, or $CNSP that gets immediatey shorted down again after the R/S. Everyone here has a shareholder bias that mames them think this company is more special than the any of the aforementioned, when it really isn't. I could be wrong. But oh wait...I can't remember the last time I was.
Retail_Warrior
Posted - 8 hours ago
$JAGX almost SABCS time, need to move up the sp so institutions will start buying.
Tapemeasure
Posted - 8 hours ago
$JAGX Almost got some of my money back today!
Stock_Hunter65
Posted - 10 hours ago
$JAGX π
Shoaquannic
Posted - 10 hours ago
$JAGX
YFZ450
Posted - 11 hours ago
$JAGX easy block lol proof the truth hurts.... sad sad sad
Rampart1
Posted - 11 hours ago
$JAGX easy block. Paid hedge fund trolls.
YFZ450
Posted - 12 hours ago
$JAGX people probably follow this guy and will take their accounts to the grave with him lol no wonder the market is so manipulated... its like taking candy from a baby with retail...
Torobravo_1
Posted - 12 hours ago
$JAGX Are there still bears here? π€¦ββοΈ
YFZ450
Posted - 12 hours ago
$JAGX if after this next RS you don't jump in short with everything you have you honestly don't deserve to be handling your own money... ignorance is not bliss in the market... Bulls down 99% and will continue the same path... imagine if you pulled your head out and bet the other way...
ScottyDoesntKnowMeSon
Posted - 13 hours ago
$JAGX $16
No partner needed
Torobravo_1
Posted - 14 hours ago
$JAGX It is a speculative stock, but at the same time with many catalysts, attractive products, which is easy if Lisa lets it run float 7.71M
Rampart1
Posted - 14 hours ago
$JAGX like wow man. π€π»
byers07
Posted - 14 hours ago
$JAGX Looks to me like it is coming out of a base pattern. Curling up next week IMO
Awaywegomoon
Posted - 14 hours ago
$JAGX nobody wants to be a partner to a product that dosent make more than my little sister that works at mcdonalds.
Awaywegomoon
Posted - 15 hours ago
$JAGX lol, hanible brought up the same point i did. Revenues for canalevia for dogs is minimal at best. They talk about exersise induced diarrhea in dogs but what responsible dog owner overworks their dog? Certainly not one that cares if it gets diarrhea. A responsible dog owner gets a remedy that works the same day, not weeks.
Torobravo_1
Posted - 16 hours ago
$JAGX Soon this will cost more than 6 dollars
Torobravo_1
Posted - 16 hours ago
$JAGX Pivot Point 3rd Level Resistance 1.0420
Torobravo_1
Posted - 16 hours ago
$JAGX he who seeks, finds... buy and stay long
Rampart1
Posted - 16 hours ago
$JAGX these PRs are great. Can't wait until hedge funds and MMs release these to run. πͺπ»πͺπ»
Awaywegomoon
Posted - 17 hours ago
$JAGX The absolute most absurd p.R. In history. Sb 300 is crofelemer! Just cheaper to make supposedly. Why would you need to use sb300 when you only sell $45k worth per quarter for dogs??.
Hannibal_Smith
Posted - 17 hours ago
$JAGX I mean by this... As a company... keep the focus on the data readout of CID in breast cancer patients. SABCS will release the abstract text monday november 25th after market close. PR problably pre market tuesday. Keep the focus on that instead of this non PR
TimeForChangeNow
Posted - 17 hours ago
$JAGX Thats the news, that will not make any monies here WTH. CRAP!
Hannibal_Smith
Posted - 17 hours ago
$JAGX Let's be honest... These PR's are useless, and secondly.. We have seen what Canalevia generates as revenue... it's not particularly what this stock needs
RazorETC_F150Lightning
Posted - 17 hours ago
$JAGX conversations with the new partner could already be happening ππ½π€π½π€·π½ββοΈ
DonCorleone77
Posted - 17 hours ago
$JAGX Jaguar Health seeking partner to develop, commercialize NP300 Jaguar Health announced that it is seeking a partner to fund and execute the development and commercialization of NP300, the company's prescription drug candidate for the treatment of general, non-infectious diarrhea in dogs, in exchange for commercial rights to the product in the U.S. NP300 is a novel antisecretory drug with a similar mechanism of action to Canalevia-CA1, the company's conditionally approved prescription drug for the treatment of chemotherapy-induced diarrhea in dogs. NP300 has demonstrated safety in dogs and is sustainably derived from the Croton lechleri tree, the same source as that for crofelemer.